Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599792 | 0.89 | ALDH1A1 (0.47) | ALDH1A1TDP1TAAR1F2L3MBTL1 | |
| SCHEMBL4599115 | 0.81 | TAAR1 (0.47) | ALDH1A1FAAHTAAR1FDFT1 | |
| SCHEMBL23665653 | 0.80 | TAAR1 (0.46) | ALDH1A1TAAR1GAAFDFT1 | |
| SCHEMBL4599667 | 0.79 | FAAH (0.49) | ALDH1A1SMN1; SMN2FAAHTDP1F2 | |
| SCHEMBL1827598 | 0.78 | SIGMAR1 (0.49) | ALDH1A1L3MBTL1GAALMNA | |
| SCHEMBL10179888 | 0.77 | PPARA (0.54) | ALDH1A1SMN1; SMN2FAAHF2 | |
| SCHEMBL3579723 | 0.77 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2FAAHTDP1F2 | |
| SCHEMBL1826630 | 0.77 | PLAU (0.48) | ALDH1A1SMN1; SMN2FAAH | |
| SCHEMBL1825995 | 0.77 | CA12 (0.54) | ALDH1A1FAAHLMNA | |
| SCHEMBL1826562 | 0.77 | CA12 (0.49) | ALDH1A1FAAHL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1910320-A2 | INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-04-16 | — | — | EP | claimed |
| WO-2007011065-A2 | INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-01-25 | — | — | WO | claimed |